搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The Pharma Letter
15 小时
UCB reveals Roche deal on bepranemab terminated
UCB today announced that the company has regained all global rights to bepranemab following termination of a collaboration ...
The Pharma Letter
19 小时
Ariceum reports promising data for new lung cancer treatment
Berlin, Germany-based Ariceum Therapeutics presented promising preclinical data at EANM 2024 on its radiop5Ac-satoreotide for ...
The Pharma Letter
21 小时
ICER raises pricing concerns ahead of US FDA acoramidis verdict
ICER has released its final report on treatments for transthyretin amyloid cardiomyopathy, evaluating Pfizer’s Vyndamax, ...
The Pharma Letter
20 小时
New gene therapy could provide two-eye option for wet AMD
Regenxbio and AbbVie announced positive Phase II results for gene therapy ABBV-RGX-314 in wet AMD, showing a 97% reduction in ...
The Pharma Letter
15 小时
NICE recommends Voydeya for PNH
UK pharma major AstraZeneca’s Alexion Rare Disease unit has received a positive recommendation for Voydeya (danicopan), from ...
The Pharma Letter
15 小时
NICE recommends Ipsen’s Iqirvo for PBC, a rare liver disease
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg ...
The Pharma Letter
20 小时
SERB Pharma expands emergency care portfolio with Aurlumyn
Philadelphia-based SERB Pharmaceuticals has acquired Aurlumyn, the only FDA-approved treatment for severe frostbite in the ...
The Pharma Letter
22 小时
J&J’s SC Tremfya could set new standard in Crohn's disease treatment
Tremfya (guselkumab) demonstrated strong results in the Phase III GRAVITI trial, marking a major breakthrough in the ...
The Pharma Letter
22 小时
Aculys touts positive Phase III data for pitolisant for narcolepsy
Japanese clinical-stage biotech Aculys Pharma announced that pitolisant (BF2.649), a histamine H3 receptor antagonist/inverse ...
The Pharma Letter
20 小时
Otsuka announces positive Phase III trial of sibeprenlimab
Otsuka Pharmaceutical (TYO: 4578) today announced positive top-line interim data from the ongoing Phase III clinical trial of ...
The Pharma Letter
15 小时
Telix spins off radiopharma unit to form Rhine Pharma
Melbourne, Australia-based Telix Pharmaceuticals has launched Rhine Pharma, a subsidiary focused on enhancing global access ...
The Pharma Letter
19 小时
FDA approves new presentation of biosimilar drug Selarsdi
Iceland-based Alvotech and the US unit of Israel’s of Teva Pharmaceutical Industries today revealed that that the US Food and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈